Ruxandra Teslo (Works In Progress)

Ruxandra Teslo Breaks Down Anthropic's Protein Results

Ruxandra Teslo, writer and editor at Works In Progress, explains the science: drugs target proteins, AlphaFold predicts protein structures, and models like David Baker's RF Diffusion (2023) already generate binders — Claude Science acts as a 'mini scientist' orchestrating these open-source tools with specialized tacit knowledge. She argues binder design is not the main bottleneck in drug discovery (finding which proteins to target is), so this is not an AlphaFold moment; the real significance is automating scientific pipelines. She notes the biology community is broadly excited about AI but disappointed the open-source models weren't credited, and she's skeptical all diseases will be cured in 10 years.

1:38:10